UBS O'Connor’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-447,500
Closed -$1.71M – 1061
2022
Q2
$1.71M Hold
447,500
– – 0.02% 686
2022
Q1
$927K Sell
447,500
-131,900
-23% -$387K 0.01% 707
2021
Q4
$589K Buy
579,400
+263,000
+83% +$1.27M 0.01% 681
2021
Q3
$296K Buy
316,400
+225,000
+246% +$795K ﹤0.01% 683
2021
Q2
$105K Buy
+91,400
New +$524K ﹤0.01% 823
2021
Q1
– Sell
-450,000
Closed -$22K – 1034
2020
Q4
$22K Hold
450,000
– – ﹤0.01% 575
2020
Q3
$442K Hold
450,000
– – 0.01% 265
2020
Q2
$551K Sell
450,000
-450,000
-50% -$1.72M 0.01% 312
2020
Q1
$866K Sell
900,000
-985,000
-52% -$4.99M 0.02% 233
2019
Q4
$2.28M Sell
1,885,000
-30,000
-2% -$134K 0.06% 184
2019
Q3
$4.24M Sell
1,915,000
-250,000
-12% -$806K 0.12% 128
2019
Q2
$4.05M Sell
2,165,000
-785,000
-27% -$4.96M 0.08% 113
2019
Q1
$2.15M Buy
2,950,000
+374,500
+15% +$3.52M 0.06% 157
2018
Q4
$3.27M Buy
2,575,500
+400,000
+18% +$5.49M 0.12% 102
2018
Q3
$679K Buy
2,175,500
+155,000
+8% +$2.2M 0.02% 220
2018
Q2
$1.22M Buy
+2,020,500
New +$13.6M 0.02% 197

Other funds holding ENDP

UBS O'Connor's ENDP Position: Q2 2021 in Review

UBS O'Connor sold out of Endo International plc (ENDP) in Q2 2021, closing a stake of 64,474 shares — an estimated $370K sold.

UBS O'Connor first reported a position in ENDP in Q2 2019 and held it in 8 quarters. The position peaked at $1.97M in Q4 2019. 203 funds tracked by Wall St. Rank hold ENDP as of Q2 2021.

  • UBS O'Connor reported no remaining Endo International plc position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 64,474 Endo International plc shares in Q2 2021, an estimated $370K.
  • UBS O'Connor first reported a position in Endo International plc in Q2 2019 and held it in 8 quarters.
  • UBS O'Connor's Endo International plc position peaked at $1.97M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held Endo International plc as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.